Sonova H Ag
🇬🇧XLON.0QPYUnited KingdomNot reported
Price£240.60+1.70 (+0.71%)
Latest anomalies
Very negative 14 detected in the last 120 days
- High: 3
- Medium: 9
- Low: 2
12-1M momentum: flipped sign, from negative to positive
Volume: a spike above the 20-day average
12-1M momentum: flipped sign, from negative to positive
52-week high: the price is trading close to this level
Volume: a spike above the 20-day average
Free with a Finzer account.
Profile
- United Kingdom
Identity
- Exchange
- London Stock Exchange . XLON
- Type
- Stock
- ISIN
- CH0012549785
- CUSIP
- Not reported
Company
- Employees
- 18,335
- Headquarters
- Stäfa, United Kingdom
- Website
- https://www.sonova.com
Market
- Shares outstanding
- 65.3M
- Market cap
- £13.03B
Key dates
- Next earnings
- Nov 12, 2026
Highlights
- Market cap
- £13.03B
- EPS LTM
- CHF 16.34
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- CHF 5.42B+61.13%up year on year
- Net income
- CHF 979.45M+50.94%up year on year
- Gross margin
- 70.48%-2.05%down year on year
- Free cash flow
- CHF 1.06B+26.33%up year on year
Latest news
News is not sourced for this exchange.
Business summary
Sonova H Ag is listed on London Stock Exchange (United Kingdom) under the ticker 0QPY. Its market capitalisation is £13.03B, from 65.3M shares outstanding, as of . Across the 253 trading sessions to the shares traded between £163.20 and £248.20, and the last close of £240.60 sits 91% of the way up that range. The company is headquartered in Stäfa, United Kingdom, and employs about 18,335 people. This is the London Stock Exchange listing of Sonova H Ag; its primary listing is SOON on SIX Swiss Exchange.
Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segment engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products directly to end consumers through its own store network; wholesales to independent audiologists, third party retail chains, and multinational and government customers; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.